Weekly Quality Compounders Watchlist – Week 14, March 30, 2026 | Titan Biotech #1 Pick

Video: Inventory Turnover Ratio Samjhiye — Quality Business Ki Pehchan Karen (Hindi)
March 30, 2026
Sold a Quality Stock Too Early? Why Buying It Back at a Higher Price Is the Smartest Move You Can Make — Lessons from Buffett, Lynch and Fisher
March 30, 2026
Show all

This week's Quality Compounders Watchlist by Manish Goel features 6 high-quality Indian small/mid-cap stocks with high ROCE, zero debt, and strong earnings growth. Titan Biotech (BSE: 524717) remains our #1 conviction pick. Published by multibaggershares.com.

⚠️ Anti-F&O Warning: SEBI data shows 90% of F&O traders lose money. F&O is gambling — not investing. Focus on quality businesses for long-term wealth creation. Stay away from tips and intraday trading.

This week’s watchlist features fundamentally strong Indian small & mid-cap businesses selected for their high ROCE, debt-free balance sheets, consistent earnings growth, and strong promoter conviction. Titan Biotech remains our #1 conviction pick — here are other quality names worth watching alongside it.


#1 TOP PICK
⭐ CONVICTION BUY

Titan Biotech Ltd

BSE: 524717 | Biochemicals & Fermentation | Small Cap

Current Price
₹458

Market Cap
₹1,892 Cr

ROCE
16.9%

ROE
15%

Promoter Holding
55.78%

Debt Status
Almost Debt-Free ✓

📊 Stock Price CAGR (Multi-Year Compounder)

1 Year
310%
5 Year
61% p.a.
10 Year
49% p.a.

💰 Q3 FY26 Financial Performance

Revenue: ₹56.51 Cr | Net Profit: ₹8.53 Cr (↑ 94% YoY) — The business is accelerating. Fermentation-based biochemicals serving pharma, food, and agriculture sectors with dominant niche positioning.

🏆 Why It’s Our #1 Pick: Titan Biotech is the complete package — exceptional long-term compounding track record (49% CAGR over 10 years), accelerating profitability (+94% YoY), almost debt-free, strong promoter conviction, and a tiny market cap of just ₹1,892 Cr. This is precisely the kind of hidden gem that creates generational wealth. Our research on Titan Biotech has been shared with 23 top investors including Mohnish Pabrai.

#2 WATCHLIST

Jyoti Resins & Adhesives Ltd

BSE: 514448 | Adhesives & Sealants | Small Cap (₹887 Cr)

Price (Mar 27)
₹739
ROCE
50%
ROE (3Y avg)
44.8%
Profit CAGR (5Y)
56.4%
Debt
Debt-Free ✓
P/E
12.7x

Why Watch: India’s #2 wood adhesive brand (Euro 7000), targeting ₹500 Cr revenue by FY29. Exceptional 50% ROCE + debt-free + 56% profit CAGR. Trading at a 36% discount to peers at just 12.7x P/E. A classic quality compounder in a non-cyclical niche.

#3 WATCHLIST

Nesco Ltd

BSE: 505355 | Real Estate / Exhibition & Convention Centers | Small-Mid Cap

ROCE
22.4%
Debt
Debt-Free ✓
Business
MICE + IT Park

Why Watch: Owner-operator model with irreplaceable real estate assets (BEC Mumbai — India’s largest exhibition center). Debt-free with 22.4% ROCE. Direct beneficiary of India’s booming MICE (Meetings, Incentives, Conferences, Exhibitions) industry. Consistent cash generation with minimal capex requirements.

#4 WATCHLIST

Maharashtra Seamless Ltd

BSE: 500265 | Steel Pipes & Tubes | Mid Cap

D/E Ratio
Zero ✓
Profit CAGR (3Y)
68.9%
Sector
Oil & Gas / Infra

Why Watch: Zero debt with a blistering 68.9% profit CAGR over 3 years. A key supplier of seamless tubes to oil & gas and power sectors — directly benefiting from India’s infrastructure and energy push. Strong balance sheet gives it pricing power and resilience through commodity cycles.

#5 WATCHLIST

Garuda Construction & Engineering Ltd

NSE: GARUDA | Infrastructure & Construction | Small Cap

ROCE
30%
Profit CAGR
118%
Debt
Negligible ✓
P/E
~21x

Why Watch: A newly listed construction gem (Oct 2024) with an exceptional 118% profit CAGR and 30% ROCE, significantly above the industry median of 18%. Negligible debt. Serves government infra and real estate projects. At 21x P/E, still reasonably priced for the quality of growth.

#6 WATCHLIST

Integrity Infrabuild Ltd

Micro Cap | Infrastructure | Piotroski Score: 7/9

Price
₹137
ROCE
29.8%
ROE
61.3%
Revenue Growth (QoQ)
+42.7%
P/E
15.8x
Market Cap
₹59 Cr

Why Watch: Ultra-micro-cap with explosive metrics — 61.3% ROE, 29.8% ROCE, 42.7% revenue growth, and a Piotroski score of 7/9 indicating strong financial health. At just ₹59 Cr market cap and 15.8x P/E, this is the kind of deeply undervalued name that rewards patient investors. High risk but extraordinary upside potential. Do thorough due diligence.


🎓 Learn to Find Your Own Multibaggers

Watch our complete investing course to master the art of identifying quality compounders — just like Titan Biotech.

▶ Watch Free Investing Course on YouTube

Curated by Manish Goel | multibaggershares.com

Disclaimer: This watchlist is for educational and informational purposes only and does not constitute investment advice or a solicitation to buy or sell any securities. Stock markets involve significant risk. Past performance is not a guarantee of future returns. Please do your own due diligence and consult a SEBI-registered investment advisor before making any investment decisions. The author may or may not hold positions in the stocks mentioned. multibaggershares.com | Manish Goel

+91-8448836436